Feature Channels:

AIDS and HIV

Filters:

  • (Press "esc" to clear)

Medicine

Channels:

Keywords:

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 30-Jul-2015 2:00 PM EDT

Medicine

Channels:

Keywords:

TSRI Researcher Wins $4.5 Million in Grants to Support Development of AIDS Vaccine

ward_andrew.jpg

The Scripps Research Institute has been awarded two grants from the Bill & Melinda Gates Foundation totaling more than $4.5 million to fund new tools to collect and process high-resolution images of HIV proteins interacting with antibodies with goal to develop a vaccine against HIV/AIDS.

Medicine

Science

Life

Business

Social and Behavioral Sciences

Channels:

New Target to Treat Depression, Sound Waves to Combat Tumors, and Improving Blood Vessels with Age, Top Stories 22 July 2015

Other topics include nursing research, treating hep C and HIV, and more

Medicine

Channels:

Keywords:

New Drug Combination Treats Hepatitis C Patients Also Infected with HIV

Researchers at the University of California, School of Medicine found a new combination that effectively treats hepatitis C (HCV) patients co-infected with human immunodeficiency virus type 1 (HIV).

Medicine

Channels:

Keywords:

New Study Finds Screening HIV Patients for Cryptococcal Antigen Saves Lives

The CrAg Lateral Flow Assay (LFA) a novel, rapid diagnostic test, is playing a crucial role in saving lives all over the world. The CrAg LFA tests for an infection called Cryptococcosis, which kills over 600,000 people every year, primarily in HIV/AIDS patients. Because of the ease-of-use and room temperature storage, the CrAg LFA, developed by IMMY, is the only test capable of bridging the gap between this disease and the life-saving medicine these patients need.

Medicine

Channels:

Keywords:

New Evidence that Genetic Differences May Help Explain Inconsistent Effectiveness of Anti-HIV Drug

Research with human tissue and cells suggests that genetic variations, in addition to failure to comply with treatment regimens, may account for some failures of an anti-HIV drug to treat and prevent HIV infection.

Medicine

Channels:

Keywords:

Scripps Research Institute-Designed Drug Candidate Significantly Reduces HIV Reactivation Rate

Susana_Valente.jpg

Scientists from the Florida campus of The Scripps Research Institute have shown that, unlike other antiretroviral therapies, a natural compound called Cortistatin A establishes a near-permanent state of latency and greatly diminishing the HIV virus’ capacity for reactivation.

Medicine

Channels:

Keywords:

Scientists Unravel Elusive Structure of HIV Protein

HIV-Capsid-Protein_1.jpg

HIV, or human immunodeficiency virus, is the retrovirus that leads to acquired immunodeficiency syndrome or AIDS. Globally, about 35 million people are living with HIV, which constantly adapts and mutates creating challenges for researchers. Now, scientists at the University of Missouri are gaining a clearer idea of what a key protein in HIV looks like, which will help explain its vital role in the virus’ life cycle. Armed with this clearer image of the protein, researchers hope to gain a better understanding of how the body can combat the virus with the ultimate aim of producing new and more effective antiviral drugs.

Medicine

Channels:

Keywords:

Needle Exchanges Can Prevent More HIV Outbreaks Like One in Indiana

Congress needs to immediately lift the ban on federal funding for needle exchange programs to counter the threat of HIV outbreaks among injection drug users like the one that has seen an alarming number of new cases erupt in a single rural Indiana county.

Medicine

Channels:

Keywords:

PrEP Data Links Anti-HIV Immune Response to Reduce Chance of Infection

Research published in the Proceedings of the National Academy of Sciences found that some individuals exposed to HIV-1, but who remain uninfected, have a certain pattern of virus-specific immune responses that differentiated them from individuals who became infected.